Pipeline
We are a research-driven biotech company dedicated to the discovery of first-in-class therapies addressing unmet needs. Our platforms and portfolio deliver NCEs and protein therapeutics against novel targets of relevance in oncology and neurodegeneration.
![](https://www.almacgroup.com/discovery/wp-content/uploads/sites/2/2020/10/debiopharm.png)
![](https://www.almacgroup.com/discovery/wp-content/uploads/sites/2/2020/10/debiopharm.png)
![](https://www.almacgroup.com/discovery/wp-content/uploads/sites/2/2020/10/msd_ifl_logo.png)
![](https://www.almacgroup.com/discovery/wp-content/uploads/sites/2/2020/10/msd_ifl_logo.png)